The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes for Two Years

被引：0
|
作者：
Tosaki, Takahiro
Kamiya, Hideki
Inagaki, Akemi
Kondo, Masaki
Nagao, Eriko
Yamada, Yuichiro
Kato, Yoshiro
Tsunekawa, Shin
Himeno, Tatsuhito
Hayasaki, Tomoyo
Sato, Shiori
Nakaya, Yuki
Nakamura, Jiro
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2420-PUB
引用
收藏
页码：A631 / A631
页数：1
相关论文
共 50 条
  • [1] The Clinical Efficacy and Safety of SGLT2 Inhibitors in Japanese Patients with Type 2 Diabetes
    Tosaki, Takahiro
    Kamiya, Hideki
    Kato, Yoshiro
    Kondo, Masaki
    Nakamura, Jiro
    DIABETES, 2015, 64 : A154 - A155
  • [2] Efficacy and safety of SGLT2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes
    Nomiyama, Takashi
    Tanabe, Makito
    Murase, Kunitaka
    Motonaga, Ryoko
    Yanase, Toshihiko
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S93 - S93
  • [3] Efficacy of SGLT2 inhibitors on bone mineral density in Japanese patients with type 2 diabetes
    Kusunoki, M.
    Natsume, Y.
    Sato, D.
    Tsutsui, H.
    Sasaki, H.
    Nakamura, T.
    Miyata, T.
    Oshida, Y.
    DIABETOLOGIA, 2015, 58 : S369 - S369
  • [4] Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    CURRENT DIABETES REPORTS, 2012, 12 (03) : 230 - 238
  • [5] Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
    Muhammad A. Abdul-Ghani
    Luke Norton
    Ralph A. DeFronzo
    Current Diabetes Reports, 2012, 12 : 230 - 238
  • [6] Efficacy and safety profile of SGLT2 inhibitors in patients with type 2 diabetes and chronic kidney disease
    Scheen, Andre J.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 243 - 256
  • [7] THE EFFICACY AND SAFETY OF THE SGLT2 RECEPTOR INHIBITORS IN TRIPLE THERAPY IN PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES
    Abreu Lomba, A.
    Bedoya Joaqui, V.
    Osorio Toro, L. M.
    Munoz Lombo, J. P.
    Salgado Cifuentes, C. A.
    Campo Rivera, N.
    Casanova Valderrama, M. E.
    Carvajal Ortiz, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A138 - A138
  • [8] Effects of SGLT2 Inhibitors on Gut Microbiota in Japanese Patients with Type 2 Diabetes
    Kusunoki, Masataka
    Hisano, Fumiya
    Matsuda, Shin-Ichi
    Miyata, Tetsuro
    DIABETES, 2023, 72
  • [9] Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2
    Hopf, Maximilian
    Kloos, Christof
    Wolf, Gunter
    Mueller, Ulrich Alfons
    Mueller, Nicolle
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 8
  • [10] Efficacy and Safety of SGLT2 Inhibitors in Patients with a LVAD
    Preheim, E.
    Straw, L.
    Mardis, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S647 - S647
12345